Miltenyi Biotec, Alfred Mann Institute deal

The institute’s Accellta Ltd. subsidiary granted Miltenyi Biotec non-exclusive, worldwide rights to an Accellta patent for use in Miltenyi’s medium for stem cell cultivation. The partners could not be...